266 related articles for article (PubMed ID: 17177110)
21. Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene.
Jung D; Hagenbuch B; Fried M; Meier PJ; Kullak-Ublick GA
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G752-61. PubMed ID: 14701722
[TBL] [Abstract][Full Text] [Related]
22. SUMOylation of the farnesoid X receptor (FXR) regulates the expression of FXR target genes.
Balasubramaniyan N; Luo Y; Sun AQ; Suchy FJ
J Biol Chem; 2013 May; 288(19):13850-62. PubMed ID: 23546875
[TBL] [Abstract][Full Text] [Related]
23. Human kininogen gene is transactivated by the farnesoid X receptor.
Zhao A; Lew JL; Huang L; Yu J; Zhang T; Hrywna Y; Thompson JR; de Pedro N; Blevins RA; Peláez F; Wright SD; Cui J
J Biol Chem; 2003 Aug; 278(31):28765-70. PubMed ID: 12761213
[TBL] [Abstract][Full Text] [Related]
24. Farnesoid X receptor and bile salts are involved in transcriptional regulation of the gene encoding the human bile salt export pump.
Plass JR; Mol O; Heegsma J; Geuken M; Faber KN; Jansen PL; Müller M
Hepatology; 2002 Mar; 35(3):589-96. PubMed ID: 11870371
[TBL] [Abstract][Full Text] [Related]
25. Farnesoid X receptor, hepatocyte nuclear factors 1alpha and 3beta are essential for transcriptional activation of the liver-specific organic anion transporter-2 gene.
Ohtsuka H; Abe T; Onogawa T; Kondo N; Sato T; Oshio H; Mizutamari H; Mikkaichi T; Oikawa M; Rikiyama T; Katayose Y; Unno M
J Gastroenterol; 2006 Apr; 41(4):369-77. PubMed ID: 16741617
[TBL] [Abstract][Full Text] [Related]
26. The farnesoid X receptor regulates transcription of 3beta-hydroxysteroid dehydrogenase type 2 in human adrenal cells.
Xing Y; Saner-Amigh K; Nakamura Y; Hinshelwood MM; Carr BR; Mason JI; Rainey WE
Mol Cell Endocrinol; 2009 Feb; 299(2):153-62. PubMed ID: 19059462
[TBL] [Abstract][Full Text] [Related]
27. The atypical interaction of peroxisome proliferator-activated receptor alpha with liver X receptor alpha antagonizes the stimulatory effect of their respective ligands on the murine cholesterol 7alpha-hydroxylase gene promoter.
Gbaguidi GF; Agellon LB
Biochim Biophys Acta; 2002 Jul; 1583(2):229-36. PubMed ID: 12117567
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid response and promoter occupancy of the mouse LXRalpha gene.
Steffensen KR; Holter E; Alikhani N; Eskild W; Gustafsson JA
Biochem Biophys Res Commun; 2003 Dec; 312(3):716-24. PubMed ID: 14680824
[TBL] [Abstract][Full Text] [Related]
29. Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism.
Lan T; Rao A; Haywood J; Kock ND; Dawson PA
J Hepatol; 2012 Aug; 57(2):359-65. PubMed ID: 22542490
[TBL] [Abstract][Full Text] [Related]
30. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor.
Laffitte BA; Kast HR; Nguyen CM; Zavacki AM; Moore DD; Edwards PA
J Biol Chem; 2000 Apr; 275(14):10638-47. PubMed ID: 10744760
[TBL] [Abstract][Full Text] [Related]
31. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
32. The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4 alpha and suppressed by bile acids.
Popowski K; Eloranta JJ; Saborowski M; Fried M; Meier PJ; Kullak-Ublick GA
Mol Pharmacol; 2005 May; 67(5):1629-38. PubMed ID: 15692145
[TBL] [Abstract][Full Text] [Related]
33. An overlapping binding site in the CYP7A1 promoter allows activation of FXR to override the stimulation by LXRalpha.
Shang Q; Pan L; Saumoy M; Chiang JY; Tint GS; Salen G; Xu G
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G817-23. PubMed ID: 17690173
[TBL] [Abstract][Full Text] [Related]
34. Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19.
Miyata M; Hata T; Yamakawa H; Kagawa T; Yoshinari K; Yamazoe Y
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):41-7. PubMed ID: 22561792
[TBL] [Abstract][Full Text] [Related]
35. Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis.
van de Wiel SMW; Porteiro B; Belt SC; Vogels EWM; Bolt I; Vermeulen JLM; de Waart DR; Verheij J; Muncan V; Oude Elferink RPJ; van de Graaf SFJ
JHEP Rep; 2022 May; 4(5):100463. PubMed ID: 35462858
[TBL] [Abstract][Full Text] [Related]
36. Pleiotropic functions of the organic solute transporter Ostα-Ostβ.
Ballatori N
Dig Dis; 2011; 29(1):13-7. PubMed ID: 21691099
[TBL] [Abstract][Full Text] [Related]
37. LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression.
Tamura K; Chen YE; Horiuchi M; Chen Q; Daviet L; Yang Z; Lopez-Ilasaca M; Mu H; Pratt RE; Dzau VJ
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8513-8. PubMed ID: 10890879
[TBL] [Abstract][Full Text] [Related]
38. Hepatocyte nuclear factor-4{alpha} regulates the human organic anion transporter 1 gene in the kidney.
Ogasawara K; Terada T; Asaka J; Katsura T; Inui K
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1819-26. PubMed ID: 17344191
[TBL] [Abstract][Full Text] [Related]
39. Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.
Matsukuma KE; Bennett MK; Huang J; Wang L; Gil G; Osborne TF
J Lipid Res; 2006 Dec; 47(12):2754-61. PubMed ID: 16957179
[TBL] [Abstract][Full Text] [Related]
40. Use of Saccharomyces cerevisiae in the identification of novel transcription factor DNA binding specificities.
Henry KW; Carey B; Howard WR; Hoefner D; Noonan DJ
Yeast; 2001 Mar; 18(5):445-54. PubMed ID: 11255252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
